Pharmigene, Inc.

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. Its offerings include contract development and manufacturing organization services, molecular diagnostic reagents, and testing products for pharmacogenomics, targeted cancer therapy, disease risk assessment, and functional medicine. The company also sells platforms such as single-cell analysis and spatial gene expression, single-cell and spatial transcriptomics data analysis software, genomic structural variation mapping, whole-genome precision annotation, precise immune cell identification, automated tissue dissociators, and clinical HLA testing. Founded in 2005, Pharmigene is headquartered in Taipei, Taiwan.